Quidelortho CORP Form 4 insider transactions

Micah W Young, Chief Financial Officer of QuidelOrtho Corp, received 356,555 shares of common stock on July 15, 2026.

Bryan Michael Hanson, EVP Global Port. Mgmt & Mkting at QuidelOrtho Corp, reported transactions involving common stock and restricted stock units.

QuidelOrtho Corp. director Kenneth J. Widder received a significant equity grant comprising restricted stock units, with vesting schedules extending into 2027.

QuidelOrtho Corp reports a grant of restricted stock units to Director R. Scott Huennekens.

John R. Chiminski, a Director at QuidelOrtho Corp, was granted restricted stock units as compensation for services.

Joseph D. Wilkins Jr., a Director at QuidelOrtho Corp, was granted 15,532 restricted stock units on June 25, 2026, which are set to vest on June 25, 2027.

Ann D. Rhoads, a Director at QuidelOrtho Corp, acquired restricted stock units valued at approximately $0, with vesting scheduled through March 2027.

Mary Lake Polan, Ph.D., a Director at QuidelOrtho Corp, received a significant equity grant comprising restricted stock units.

Michael Edward L. reports receipt of restricted stock units and conversion of existing units as part of his director compensation at QuidelOrtho Corp.

Evelyn S. Dilsaver, a Director at QuidelOrtho Corp, was granted 15,532 restricted stock units on June 25, 2026, vesting on June 25, 2027.

QuidelOrtho Corp. director Kenneth F. Buechler reports the acquisition of restricted stock units as compensation for services.

QuidelOrtho Corp director Kenneth J. Widder reported the vesting of restricted stock units, converting them into common stock.

Director Mary Lake Polan reported transactions involving restricted stock units and common stock of QuidelOrtho Corp.

QuidelOrtho Corp. director Kenneth F. Buechler reported transactions involving the release of restricted stock units.

Director Edward L. Michael of QuidelOrtho Corp (QDEL) reported a transaction involving the release of restricted stock units on June 6, 2026.

Matthew Strobeck, a Director at QuidelOrtho Corp, reported transactions involving the acquisition and disposition of common stock and restricted stock units.

QuidelOrtho Corp. reports a Form 4 filing detailing director Kenneth J. Widder's acquisition of 6,829 common stock shares.

QuidelOrtho Corp. Director Mary Lake Polan, Ph.D. reported transactions involving the acquisition and disposition of company stock, including the vesting of restricted stock units.

QuidelOrtho Corp. reports a Form 4 filing detailing a transaction by Director Kenneth F. Buechler involving the acquisition of 6,829 shares of common stock.

John R. Chiminski, a Director at QuidelOrtho Corp, acquired 6,829 shares of common stock upon the vesting of restricted stock units.

QuidelOrtho Corp. Director R. Scott Huennekens reported the vesting of 6,829 restricted stock units on May 29, 2026.

Joseph D. Wilkins Jr., a Director at QuidelOrtho Corp, acquired 6,829 shares of common stock upon the vesting of restricted stock units.

Ann D. Rhoads, a Director at QuidelOrtho Corp, acquired 6,829 shares of common stock through the release of restricted stock units.

QuidelOrtho Corp. reports a Form 4 filing detailing the acquisition of common stock by Director Edward L. Michael.

Ann D. Rhoads, a Director at QuidelOrtho Corp, reported transactions involving the release of restricted stock units and the acquisition of common stock.

Philip D. McLellan, Chief Operations Officer of QuidelOrtho Corp, reported a disposition of 699 common shares to cover tax withholding obligations.

Chief Operations Officer Philip D. McLellan acquired 3,238 shares of QuidelOrtho common stock via RSU vesting, with 1,162 shares withheld for taxes.

EVP Bryan Hanson acquired 3,508 shares of QuidelOrtho common stock via restricted stock unit vesting, with a portion withheld for taxes.

Chief Legal Officer Nathaniel Sisitsky was granted 73,435 restricted stock units and 73,434 stock options by QuidelOrtho Corp.

QuidelOrtho's Chief Financial Officer, Joseph M. Busky, reported the vesting of restricted stock units and subsequent share disposition for tax obligations.